IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue346,639298,276273,957149,555
Cost of Revenue199,501167,634141,734126,396
Gross Profit147,138130,642132,22323,159
Operating Expenses
Research Development----
Selling General and Administrative241,291233,123173,281125,247
Non Recurring----
Others----
Total Operating Expenses448,903406,971315,996251,643
Operating Income or Loss-102,264-108,695-42,039-102,088
Income from Continuing Operations
Total Other Income/Expenses Net-180,104-8,242-39,669-40,581
Earnings Before Interest and Taxes-102,264-108,695-42,039-102,088
Interest Expense-37,724-36,370-39,153-31,096
Income Before Tax-282,368-116,937-81,708-142,669
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-282,368-116,937-81,708-142,669
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-282,368-116,937-81,708-142,669
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-282,368-116,937-81,708-142,669